Is it Possible to Teach Scientific Creativity in the Pharmaceutical Sciences? Anecdotes and Memorabilia

Webster's new collegiate dictionary. Springfield, MA: G & C Merriam Company, 1977.

Hanford WE . Chem Eng News 1958 (Dec 8):70.

Saunders JH . Careers in industrial research and development. New York: Marcel Dekker Inc. 1974: 145–62.

Hammond AL ., ed. Science 84 1984; 5, (Nov 5): 35–157.

Nelson P . Naturalness in theoretical physics. Am Sci 1985; 73: 60–7.

Ferris T . Einstein's wonderful year. Science 84 1984; (Nov 5): 61–3.

Sandage A . Inventing the beginning. Science 84 1984; (Nov 5): 111–3.

Friedel R . The plastics man. Science 84 1984; (Nov 5): 49–51.

Miller GA . The test. Science 84 1984; (Nov 5): 55–7.

Thomas L . Medicine's second revolution Science 84 1984; (Nov 5): 93–5.

Watson JD . The double helix. New York: New American Library, 1969.

Baltimore D . The brain of a cell. Science 84 1984; (Nov 5): 149–51.

Garrett ER Carper RF . Prediction of stability in pharmaceutical preparations. I. Color stability in liquid multisulfa preparation. J Am Pharm Assoc 1955; 44: 515–8.

Garrett ER . Prediction of stability in pharmaceutical preparations. II. Vitamin stability in liquid multivitamin preparations. J Am Pharm Assoc 1956; 45: 171–8.

Garrett ER . Prediction of stability in pharmaceutical preparations. III. Comparison of vitamin stabilities in different multivitamin preparations. J Am Pharm Assoc 1956; 45: 470–3.

Garrett ER . The Volwiler Lecture. A personal appraisal of progress, prospects and perspectives in the pharmaceutical sciences and pedagogy. Am J Pharm Educ 1980; 44: 347–58.

Snyder SH . Medicated minds. Science 84 1984; (Nov 5): 141–2.

Garrett ER Hunt CA . Physicochemical properties, solubility and protein binding of delta-tetrahydrocannabinol. J Am Pharm Assoc 1974; 63: 1056–64.

Garrett ER Gurkan T . Pharmacokinetics of morphine and its surrogates. II: Methods of separation of stabilized heroin and its metabolites from hydrolysing biological fluids and applications of protein binding and red blood cell partition studies. J Pharm Sci 1979; 68: 26–32.

Garrett ER Hunt CA . Pharmacokinetics of delta-tetrahydrocannabinol in dogs. J Pharm Sci 1977; 66: 395–407.

Hinderling PH Garrett ER . Pharmacokinetics of B-methyldigoxin in healthy humans. III: Pharmacodynamic correlations. J Pharm Sci 1977; 66: 326–9.

Hinderling PH Garrett ER . Pharmacokinetics of the antiarrhythmic disopyramide in healthy humans: Correlations of the kinetics of the drug and its effect. J Pharm Sci 1976; 4: 231–42.

Garrett ER . Individual pharmacokinetic profile and proper modern drug usage. Excerpta Medica 1973; 5: 52–61.

Garrett ER Gravenstein JS . Pharmacokinetic models and their use in clinical investigations, 5th International Congress of Chemotherapy, July, 1967.

Garrett ER . The significance of properly designed preclinical studies in the clinical evaluation of new drugs. Int J Clin Pharmacol 1970; 4: 6–20.

Balant L Revillard C Garrett ER . Pharmacocinetique clinique. Schweiz Med Wochenschr 1976; 106: 33–43.

Garrett ER . The pharmacokinetic bases of biological response quantification in toxicology, pharmacology and pharmacodynamics. In: Jucker E ., ed. Progress in drug research. Basel and Stuttgart: Birkhauser Verlag, 1977: 105–230.

Garrett ER . The clinical significance of pharmacokinetics. In: Dengler HJ , ed. Pharmacological and clinical significance of pharmacokinetics. Verlag Stuttgart-New York: FK Schattauer, 1970: 5–21.

Garrett ER . Pharmacokinetics and their clinical significance. Int J Clin Pharmacol 1969; 3: 193.

Garrett ER . Classical pharmacokinetics to the frontier. Pharmacology and Pharmacokinetics 1973; 1: 341–61.

Kuhne P . Individuelle pharmakologie. Das risiko der sicherheit In: Das risiko der sicherheit: Verlag Medical Tribune GmbH, 1969: 63–5.

Garrett IB . The Order of the bee-scientific research and productivity. Am Bee Journal 1970; 5: 185.

Bacon F . Novum Organum I (XCV).